You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

full treatment-free remission

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

Recruiting
  • CML
  • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
  • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
    FUNDALEU
Jun 29, 2023

Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Treatment-free Remission
  • TFR(Treatment-Free Remission)
  • (no location specified)
Jun 27, 2022

Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

Not yet recruiting
  • Chronic Myeloid Leukemia, BCR/ABL-Positive
    • Taipei, Taiwan
      National Taiwan University Hospital
    Jul 24, 2022

    Treatment Free Remission, Chronic Myeloid Leukemia Trial in Turin

    Recruiting
    • Treatment Free Remission
    • Chronic Myeloid Leukemia
      • Turin, Italy
        Division of Hematology-AO Mauriziano Hospital, University of Tur
      Nov 17, 2021

      Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia
      • Detroit, Michigan
      • +1 more
      May 3, 2022

      Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)

      Recruiting
      • Acute Myeloid Leukemia
      • Decitabine and Cedazuridine
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 10, 2022

      Outcomes of Tyrosine Kinase Inhibitor(TKI)Stopping in Chronic

      Recruiting
      • Folate
      • +2 more
        • Nantong, China
          Affliated Hospital of Nantong University
        Dec 13, 2021

        Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

        Not yet recruiting
        • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
        • (no location specified)
        Jun 7, 2022

        Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic

        Withdrawn
        • CLL
        • +4 more
        • Treatment Free Observation
        • Basking Ridge, New Jersey
        • +8 more
        Mar 4, 2022

        Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib followed by treatment-free)

        Active, not recruiting
        Has Results
        • Chronic Myelogenous Leukemia
        • Nilotinib followed by treatment-free
        • Fort Myers, Florida
        • +113 more
        Apr 25, 2022

        Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)

        Active, not recruiting
        Has Results
        • Chronic Myeloid Leukemia
        • Los Angeles, California
        • +61 more
        Mar 17, 2022

        Heart Failure With Reduced Ejection Fraction, Heart Rhythm Disorder Trial (GDMT)

        Not yet recruiting
        • Heart Failure With Reduced Ejection Fraction
        • Heart Rhythm Disorder
        • (no location specified)
        Nov 9, 2023

        Leukemia, Chronic Myeloid Trial in Campinas (Pioglitazone, imatinib discontinuation)

        Active, not recruiting
        • Leukemia, Chronic Myeloid
        • Campinas, SP, Brazil
          Centro de Hematologia e Hemoterapia - Universidade Estadual de C
        Nov 2, 2020

        Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Worldwide (procedure, other, drug)

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • Biospecimen Collection
        • +4 more
        • Birmingham, Alabama
        • +170 more
        Jan 30, 2023

        Follicular Lymphoma Trial in Italy (Immunochemo regimen: Rituximab-bendamustine (Arm A), Immunochemo regimen:

        Recruiting
        • Follicular Lymphoma
        • Immunochemotherapy regimen: Rituximab-bendamustine (Arm A)
        • +9 more
        • Barletta, Barletta Andria Trani, Italy
        • +68 more
        Oct 13, 2022

        Alkylating Agent-Related Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia Trial in Houston (Laboratory Biomarker

        Completed
        Has Results
        • Alkylating Agent-Related Acute Myeloid Leukemia
        • Secondary Acute Myeloid Leukemia
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 18, 2022

        Colitis Ulcerative Trial in Worldwide (SAR443122, Placebo)

        Recruiting
        • Colitis Ulcerative
        • Los Alamitos, California
        • +5 more
        Jan 20, 2023

        Relapsed/Refractory Philadelphia Positive B-precursor ALL Trial in Worldwide (Blinatumomab)

        Completed
        Has Results
        • Relapsed/Refractory Philadelphia Positive B-precursor ALL
        • Duarte, California
        • +21 more
        Sep 8, 2022

        Non-radiographic Axial Spondyloarthritis Trial (Secukinumab, Placebo)

        Not yet recruiting
        • Non-radiographic Axial Spondyloarthritis
        • (no location specified)
        Nov 16, 2022

        Posttransplant Lymphoproliferative Disorder Trial in Germany (Rituximab sc, Rituximab sc consolidation, Rituximab sc combined

        Completed
        • Posttransplant Lymphoproliferative Disorder
        • Rituximab sc
        • +3 more
        • Aachen, Germany
        • +17 more
        Aug 22, 2022

        Finland Treated With Tofacitinib for Treatment of Ulcerative

        Completed
        • Ulcerative Colitis
          • Helsinki, Finland
            Pfizer
          Dec 15, 2022

          Chronyc Myeloid Leukemia Trial in Italy, Netherlands (Imatinib, Nilotinib)

          Active, not recruiting
          • Chronyc Myeloid Leukemia
          • Alessandria, Italy
          • +81 more
          Jan 4, 2022

          Heart Diseases, Microbial Colonization, Inflammation Trial in Boston (Milk or yogurt beverage)

          Not yet recruiting
          • Heart Diseases
          • +2 more
          • Milk or yogurt beverage
          • Boston, Massachusetts
            Jean Mayer Human Nutrition Research Center on Aging
          Apr 21, 2023

          Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)

          Not yet recruiting
          • Pancreas Cancer
          • Non-Resectable Pancreas Carcinoma
          • Aalborg, Denmark
            Department of Oncology, Aalborg University Hospital
          May 1, 2023

          Lung Cancer Stage III Trial (Almonertinib)

          Not yet recruiting
          • Lung Cancer Stage III
          • (no location specified)
          Aug 8, 2023